These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 23742799)

  • 1. Acute food deprivation reverses morphine-induced locomotion deficits in M5 muscarinic receptor knockout mice.
    Steidl S; Lee E; Wasserman D; Yeomans JS
    Behav Brain Res; 2013 Sep; 252():176-9. PubMed ID: 23742799
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholinergic control of morphine-induced locomotion in rostromedial tegmental nucleus versus ventral tegmental area sites.
    Wasserman DI; Wang HG; Rashid AJ; Josselyn SA; Yeomans JS
    Eur J Neurosci; 2013 Sep; 38(5):2774-85. PubMed ID: 23773170
    [TBL] [Abstract][Full Text] [Related]  

  • 3. M5 muscarinic receptor knockout mice show reduced morphine-induced locomotion but increased locomotion after cholinergic antagonism in the ventral tegmental area.
    Steidl S; Yeomans JS
    J Pharmacol Exp Ther; 2009 Jan; 328(1):263-75. PubMed ID: 18849356
    [TBL] [Abstract][Full Text] [Related]  

  • 4. M₅ muscarinic receptors mediate striatal dopamine activation by ventral tegmental morphine and pedunculopontine stimulation in mice.
    Steidl S; Miller AD; Blaha CD; Yeomans JS
    PLoS One; 2011; 6(11):e27538. PubMed ID: 22102904
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Midbrain muscarinic receptors modulate morphine-induced accumbal and striatal dopamine efflux in the rat.
    Miller AD; Forster GL; Yeomans JS; Blaha CD
    Neuroscience; 2005; 136(2):531-8. PubMed ID: 16216430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Midbrain muscarinic receptor mechanisms underlying regulation of mesoaccumbens and nigrostriatal dopaminergic transmission in the rat.
    Miller AD; Blaha CD
    Eur J Neurosci; 2005 Apr; 21(7):1837-46. PubMed ID: 15869479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Muscarinic cholinergic receptor antagonists in the VTA and RMTg have opposite effects on morphine-induced locomotion in mice.
    Steidl S; Dhillon ES; Sharma N; Ludwig J
    Behav Brain Res; 2017 Apr; 323():111-116. PubMed ID: 28143769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Opioid-induced rewards, locomotion, and dopamine activation: A proposed model for control by mesopontine and rostromedial tegmental neurons.
    Steidl S; Wasserman DI; Blaha CD; Yeomans JS
    Neurosci Biobehav Rev; 2017 Dec; 83():72-82. PubMed ID: 28951251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Critical role of cholinergic transmission from the laterodorsal tegmental nucleus to the ventral tegmental area in cocaine-induced place preference.
    Shinohara F; Kihara Y; Ide S; Minami M; Kaneda K
    Neuropharmacology; 2014 Apr; 79():573-9. PubMed ID: 24467849
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Muscarinic receptor blockade in the ventral tegmental area attenuates cocaine enhancement of laterodorsal tegmentum stimulation-evoked accumbens dopamine efflux in the mouse.
    Lester DB; Miller AD; Blaha CD
    Synapse; 2010 Mar; 64(3):216-23. PubMed ID: 19862686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Deletion of the M5 muscarinic acetylcholine receptor attenuates morphine reinforcement and withdrawal but not morphine analgesia.
    Basile AS; Fedorova I; Zapata A; Liu X; Shippenberg T; Duttaroy A; Yamada M; Wess J
    Proc Natl Acad Sci U S A; 2002 Aug; 99(17):11452-7. PubMed ID: 12154229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential modulation by nicotine of substantia nigra versus ventral tegmental area dopamine neurons.
    Keath JR; Iacoviello MP; Barrett LE; Mansvelder HD; McGehee DS
    J Neurophysiol; 2007 Dec; 98(6):3388-96. PubMed ID: 17942622
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Muscarinic control of rostromedial tegmental nucleus GABA neurons and morphine-induced locomotion.
    Wasserman DI; Tan JM; Kim JC; Yeomans JS
    Eur J Neurosci; 2016 Jul; 44(1):1761-70. PubMed ID: 26990801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholinergic Mesopontine Signals Govern Locomotion and Reward through Dissociable Midbrain Pathways.
    Xiao C; Cho JR; Zhou C; Treweek JB; Chan K; McKinney SL; Yang B; Gradinaru V
    Neuron; 2016 Apr; 90(2):333-47. PubMed ID: 27100197
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persistent Adaptations in Afferents to Ventral Tegmental Dopamine Neurons after Opiate Withdrawal.
    Kaufling J; Aston-Jones G
    J Neurosci; 2015 Jul; 35(28):10290-303. PubMed ID: 26180204
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rewarding effects of M4 but not M3 muscarinic cholinergic receptor antagonism in the rostromedial tegmental nucleus.
    Buie N; Sodha D; Scheinman SB; Steidl S
    Behav Brain Res; 2020 Feb; 379():112340. PubMed ID: 31697984
    [TBL] [Abstract][Full Text] [Related]  

  • 17. GABA(A) receptors mediate the opposing roles of dopamine and the tegmental pedunculopontine nucleus in the motivational effects of ethanol.
    Ting-A-Kee R; Dockstader C; Heinmiller A; Grieder T; van der Kooy D
    Eur J Neurosci; 2009 Mar; 29(6):1235-44. PubMed ID: 19302158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GABA(B) receptor activation in the ventral tegmental area inhibits the acquisition and expression of opiate-induced motor sensitization.
    Leite-Morris KA; Fukudome EY; Shoeb MH; Kaplan GB
    J Pharmacol Exp Ther; 2004 Feb; 308(2):667-78. PubMed ID: 14610238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between the role of muscarinic M
    Li X; Zheng Y; Zhao X; Cui R; Li X
    Neurosci Lett; 2022 Aug; 786():136774. PubMed ID: 35809878
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intrahippocampal administration of D2 but not D1 dopamine receptor antagonist suppresses the expression of conditioned place preference induced by morphine in the ventral tegmental area.
    Haghparast A; Esmaeili MH; Taslimi Z; Kermani M; Yazdi-Ravandi S; Alizadeh AM
    Neurosci Lett; 2013 Apr; 541():138-43. PubMed ID: 23499959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.